MyFinsight
Home
About
Contact
acad: the income statement
Download
Download image
Daybue
$101,103K
(10.84%↑ Y/Y)
Nuplazid
$177,530K
(11.52%↑ Y/Y)
Total revenues
$278,633K
(11.27%↑ Y/Y)
Other income
$593K
(2.95%↑ Y/Y)
Interest income, net
$8,246K
(25.20%↑ Y/Y)
Income from operations
$35,756K
(12.99%↑ Y/Y)
Total operating
expenses
$242,877K
(11.03%↑ Y/Y)
Income tax expense
(benefit)
-$27,184K
(-549.99%↓ Y/Y)
Income before income
taxes
$44,595K
(14.92%↑ Y/Y)
Selling, general and
administrative
$133,401K
(0.08%↑ Y/Y)
Research and development
$87,829K
(31.86%↑ Y/Y)
Cost of product sales
$21,647K
(14.80%↑ Y/Y)
Net loss
$71,779K
(119.07%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
ACADIA PHARMACEUTICALS INC (ACAD)
ACADIA PHARMACEUTICALS INC (ACAD)